P4643Are we choosing the right reperfusion therapy in early presenters with ST-segment elevation myocardial infarction?
Pedro Azevedo(Algarve Biomedical Center), I Jesus(Algarve Biomedical Center), Dina Bento(Algarve Biomedical Center), Nuno Marques(Hospital do Espírito Santo), J Guedes(Algarve Biomedical Center), D Carvalho(Hospital de Faro EPE), João Bispo(Algarve Biomedical Center), Victor Brandão(Hospital de Faro EPE), Walter Santos(Hospital de Faro EPE), Sara Pereira(Hospital de Faro EPE), Jorge Mimoso(Hospital de Faro EPE)
Cited by 0
Related Papers
Assessing cognitive decline in the aging brain: lessons from rodent and human studies
|npj Aging|2023|170
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
|Journal of the American College of Cardiology|2020|104
Using ChatGPT in Software Requirements Engineering: A Comprehensive Review
|Future Internet|2024|94
Measuring healthy ageing: current and future tools
|Biogerontology|2023|40
Short- and medium-term prognosis of Takotsubo syndrome in a Portuguese population
|Revista Portuguesa de Cardiologia|2019|23